AAAAAA
Results:
1-15
|
Results: 15
Authors:
Bargoni, A
Cavalli, R
Zara, GP
Fundaro, A
Caputo, O
Gasco, MR
Citation: A. Bargoni et al., Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II - Tissue distribution, PHARMAC RES, 43(5), 2001, pp. 497-502
Authors:
Peira, E
Scolari, P
Gasco, MR
Citation: E. Peira et al., Transdermal permeation of apomorphine through hairless mouse skin from microemulsions, INT J PHARM, 226(1-2), 2001, pp. 47-51
Authors:
Cavalli, R
Gasco, MR
Barresi, AA
Rovero, G
Citation: R. Cavalli et al., Evaporative drying of aqueous dispersions of solid lipid nanoparticles, DRUG DEV IN, 27(9), 2001, pp. 919-924
Authors:
Salomone, B
Ponti, R
Gasco, MR
Ugazio, E
Quaglino, P
Osella-Abate, S
Bernengo, MG
Citation: B. Salomone et al., In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction, CLIN EXP M, 18(8), 2001, pp. 663-673
Authors:
Cavalli, R
Zara, GP
Caputo, O
Bargoni, A
Fundaro, A
Gasco, MR
Citation: R. Cavalli et al., Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I - A pharmacokinetic study, PHARMAC RES, 42(6), 2000, pp. 541-545
Authors:
Fundaro, A
Cavalli, R
Bargoni, A
Vighetto, D
Zara, GP
Gasco, MR
Citation: A. Fundaro et al., Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats, PHARMAC RES, 42(4), 2000, pp. 337-343
Authors:
Cavalli, R
Caputo, O
Gasco, MR
Citation: R. Cavalli et al., Preparation and characterization of solid lipid nanospheres containing paclitaxel, EUR J PH SC, 10(4), 2000, pp. 305-309
Authors:
Miglietta, A
Cavalli, R
Bocca, C
Gabriel, L
Gasco, MR
Citation: A. Miglietta et al., Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel, INT J PHARM, 210(1-2), 2000, pp. 61-67
Authors:
Marengo, E
Cavalli, R
Caputo, O
Rodriguez, L
Gasco, MR
Citation: E. Marengo et al., Scale-up of the preparation process of solid lipid nanospheres. Part I, INT J PHARM, 205(1-2), 2000, pp. 3-13
Authors:
Pattarino, F
Marengo, E
Trotta, M
Gasco, MR
Citation: F. Pattarino et al., Combined use of lecithin and decyl polyglucoside in microemulsions: Domainof existence and cosurfactant effect, J DISP SCI, 21(3), 2000, pp. 345-363
Authors:
Podio, V
Zara, GP
Carazzone, M
Cavalli, R
Gasco, MR
Citation: V. Podio et al., Biodistribution of stealth and non-stealth solid lipid nanospheres after intravenous administration to rats, J PHARM PHA, 52(9), 2000, pp. 1057-1063
Authors:
Cavalli, R
Bocca, C
Miglietta, A
Caputo, O
Gasco, MR
Citation: R. Cavalli et al., Albumin adsorption on stealth and non-stealth solid lipid nanoparticles, STP PHARM S, 9(2), 1999, pp. 183-189
Authors:
Zara, GP
Cavalli, R
Fundaro, A
Bargoni, A
Caputo, O
Gasco, MR
Citation: Gp. Zara et al., Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN), PHARMAC RES, 40(3), 1999, pp. 281-286
Authors:
Cavalli, R
Peira, E
Caputo, O
Gasco, MR
Citation: R. Cavalli et al., Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins, INT J PHARM, 182(1), 1999, pp. 59-69
Authors:
Pellizzaro, C
Coradini, D
Morel, S
Ugazio, E
Gasco, MR
Daidone, MG
Citation: C. Pellizzaro et al., Cholesteryl butyrate in solid lipid nanospheres as an alternative approachfor butyric acid delivery, ANTICANC R, 19(5B), 1999, pp. 3921-3925
Risultati:
1-15
|